Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Anthem, Inc.    ANTM

ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

ANTHEM, INC. : Ex-dividend day for

share with twitter share with LinkedIn share with facebook
share via e-mail
12/04/2019 EST

A dividend is removed today from Anthem, Inc.'s share.



© Factset 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ANTHEM, INC.
04:37pHealth insurer shares pummeled by Sanders surge, virus worries
RE
02/19ANTHEM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
02/10ANTHEM : Health Care Company Anthem Joins NC State's IBM Q Hub
AQ
02/04CENTENE : Profit Dented by Higher Costs
DJ
01/29ANTHEM : Falls on Weak Metric, Disappointing 2020 Guidance -- Update
DJ
01/29ANTHEM : Falls on Weak Metric, Disappointing 2020 Guidance
DJ
01/29ANTHEM : Insurer Anthem underwhelms Wall Street with 2020 forecast
AQ
01/29ANTHEM : Raises Quarterly Dividend by 19% to 95 Cents
DJ
01/29ANTHEM : Sets 2020 Outlook
DJ
01/29ANTHEM : 4Q Profit, Revenue Rise
DJ
More news
Financials (USD)
Sales 2020 117 B
EBIT 2020 8 439 M
Net income 2020 5 504 M
Debt 2020 14 634 M
Yield 2020 1,36%
P/E ratio 2020 12,9x
P/E ratio 2021 11,2x
EV / Sales2020 0,72x
EV / Sales2021 0,64x
Capitalization 70 022 M
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 346,40  $
Last Close Price 277,50  $
Spread / Highest target 41,3%
Spread / Average Target 24,8%
Spread / Lowest Target 8,11%
EPS Revisions
Managers
NameTitle
Gail Koziara Boudreaux President, Chief Executive Officer & Director
Elizabeth E. Tallett Independent Chairman
John E. Gallina Chief Financial Officer & Executive Vice President
Ramiro G. Peru Independent Director
Julie Anne Hill Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ANTHEM, INC.-2.42%74 364
UNITEDHEALTH GROUP2.53%285 928
CIGNA CORPORATION6.21%80 910
HUMANA0.86%48 836
CENTENE CORPORATION4.17%38 427
WELLCARE HEALTH PLANS5.97%17 611